Business Description
Stella Pharma Corp
ISIN : JP3399680002
Share Class Description:
TSE:4888: Ordinary SharesTotal Employee Number:
46Description
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.78 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | -1.01 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.76 | |||||
Beneish M-Score | -4.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.2 | |||||
3-Year EBITDA Growth Rate | 5.2 | |||||
3-Year EPS without NRI Growth Rate | 5.2 | |||||
3-Year FCF Growth Rate | 30 | |||||
3-Year Book Growth Rate | -8.1 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.09 | |||||
9-Day RSI | 53.57 | |||||
14-Day RSI | 46.95 | |||||
3-1 Month Momentum % | -53.16 | |||||
6-1 Month Momentum % | 45.41 | |||||
12-1 Month Momentum % | -19.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 16.75 | |||||
Quick Ratio | 11.76 | |||||
Cash Ratio | 10.86 | |||||
Days Inventory | 10390.44 | |||||
Days Sales Outstanding | 528.96 | |||||
Days Payable | 342.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.3 | |||||
Shareholder Yield % | 0.79 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 86.32 | |||||
Operating Margin % | -231.6 | |||||
Net Margin % | -241.48 | |||||
EBITDA Margin % | -229.49 | |||||
FCF Margin % | -107.04 | |||||
OCF Margin % | -103.44 | |||||
ROE % | -27.45 | |||||
ROA % | -15.8 | |||||
ROIC % | -40.17 | |||||
3-Year ROIIC % | 27.13 | |||||
ROC (Joel Greenblatt) % | -44.03 | |||||
ROCE % | -16.65 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 34.19 | |||||
PB Ratio | 4.56 | |||||
Price-to-Tangible-Book | 4.64 | |||||
EV-to-EBIT | -12.49 | |||||
EV-to-EBITDA | -12.98 | |||||
EV-to-Revenue | 29.78 | |||||
EV-to-FCF | -27.72 | |||||
Price-to-GF-Value | 0.96 | |||||
| Price-to-Net-Current-Asset-Value | 4.82 | |||||
| Price-to-Net-Cash | 14.5 | |||||
Earnings Yield (Greenblatt) % | -8 | |||||
FCF Yield % | -2.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stella Pharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 323.389 | ||
| EPS (TTM) (円) | -22.954 | ||
| Beta | -0.735 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.53 | ||
| Volatility % | 117.34 | ||
| 14-Day RSI | 46.95 | ||
| 14-Day ATR (円) | 19.972702 | ||
| 20-Day SMA (円) | 321.95 | ||
| 12-1 Month Momentum % | -19.95 | ||
| 52-Week Range (円) | 200 - 995 | ||
| Shares Outstanding (Mil) | 36.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stella Pharma Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stella Pharma Corp Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Stella Pharma Corp Frequently Asked Questions
What is Stella Pharma Corp(TSE:4888)'s stock price today?
The current price of TSE:4888 is 円325.00. The 52 week high of TSE:4888 is 円995.00 and 52 week low is 円200.00.
When is next earnings date of Stella Pharma Corp(TSE:4888)?
The next earnings date of Stella Pharma Corp(TSE:4888) is .
Does Stella Pharma Corp(TSE:4888) pay dividends? If so, how much?
Stella Pharma Corp(TSE:4888) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Stella Pharma Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers